Prot# E2020-A001-413: A 12 Week, Multicenter, Open Label Study to Evaluate the Effectiveness and Safety of Donepezil Hydrochloride (Aricept®) in Hispanic Patients with Mild to Moderate Alzheimer's Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date3/8/067/12/11

Funding

  • Eisai, Inc. and Pfizer, Inc. (E2020-A001-413)